GSK plc (GSK) Stock Overview
Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.
GSK plc (GSK)
Key Financials
Key Financials
Market Cap
100.2B
P/E Ratio
10.95
EPS (TTM)
$4.63
ROE
0.28%
GSK Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $58.14.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.95 and a market capitalization of 100.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.